Epirizole
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
4-methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidine | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number |
18694-40-1 |
| ATC code | none |
| PubChem | CID 3242 |
| DrugBank |
DB08991 |
| ChemSpider |
3129 |
| UNII |
3B46O2FH8I |
| KEGG |
D01394 |
| Chemical data | |
| Formula | C11H14N4O2 |
| Molar mass | 234.25 g/mol |
| |
| |
| | |
Epirizole (INN) is a nonsteroidal anti-inflammatory drug.
| ||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Tuesday, April 19, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
